nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextrothyroxine—SLCO4C1—Transport of vitamins, nucleosides, and related molecules—SLC29A1—pancreatic cancer	0.0273	0.0562	CbGpPWpGaD
Dextrothyroxine—SLCO4A1—Transport of vitamins, nucleosides, and related molecules—SLC29A1—pancreatic cancer	0.0273	0.0562	CbGpPWpGaD
Dextrothyroxine—SLCO1C1—Transport of vitamins, nucleosides, and related molecules—SLC29A1—pancreatic cancer	0.0229	0.0471	CbGpPWpGaD
Dextrothyroxine—TPO—Hematopoietic Stem Cell Differentiation—ABO—pancreatic cancer	0.022	0.0452	CbGpPWpGaD
Dextrothyroxine—THRB—Nuclear Receptors—NR5A2—pancreatic cancer	0.0195	0.0401	CbGpPWpGaD
Dextrothyroxine—THRA—Nuclear Receptors—NR5A2—pancreatic cancer	0.0195	0.0401	CbGpPWpGaD
Dextrothyroxine—TPO—Hematopoietic Stem Cell Differentiation—ACVR1B—pancreatic cancer	0.0192	0.0395	CbGpPWpGaD
Dextrothyroxine—THRA—Nuclear Receptor transcription pathway—NR5A2—pancreatic cancer	0.0154	0.0317	CbGpPWpGaD
Dextrothyroxine—THRB—Nuclear Receptor transcription pathway—NR5A2—pancreatic cancer	0.0154	0.0317	CbGpPWpGaD
Dextrothyroxine—TPO—Differentiation Pathway—SHH—pancreatic cancer	0.0091	0.0187	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—AHR—pancreatic cancer	0.00891	0.0183	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—SLC29A1—pancreatic cancer	0.00872	0.0179	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—NFE2L2—pancreatic cancer	0.00868	0.0179	CbGpPWpGaD
Dextrothyroxine—THRA—Endochondral Ossification—PTHLH—pancreatic cancer	0.00667	0.0137	CbGpPWpGaD
Dextrothyroxine—THRA—Endochondral Ossification—PTCH1—pancreatic cancer	0.00667	0.0137	CbGpPWpGaD
Dextrothyroxine—THRB—RXR and RAR heterodimerization with other nuclear receptor—PPARG—pancreatic cancer	0.0064	0.0132	CbGpPWpGaD
Dextrothyroxine—THRA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—pancreatic cancer	0.0064	0.0132	CbGpPWpGaD
Dextrothyroxine—SLCO4A1—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.00587	0.0121	CbGpPWpGaD
Dextrothyroxine—SLCO4C1—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.00587	0.0121	CbGpPWpGaD
Dextrothyroxine—THRB—SIDS Susceptibility Pathways—SSTR1—pancreatic cancer	0.00546	0.0112	CbGpPWpGaD
Dextrothyroxine—SLC7A5—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.00537	0.011	CbGpPWpGaD
Dextrothyroxine—THRB—SIDS Susceptibility Pathways—SSTR2—pancreatic cancer	0.00525	0.0108	CbGpPWpGaD
Dextrothyroxine—TPO—Hematopoietic Stem Cell Differentiation—NOTCH1—pancreatic cancer	0.00494	0.0102	CbGpPWpGaD
Dextrothyroxine—SLCO1C1—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.00492	0.0101	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—HES1—pancreatic cancer	0.00484	0.00996	CbGpPWpGaD
Dextrothyroxine—TPO—Amino acid and derivative metabolism—ARG2—pancreatic cancer	0.00483	0.00994	CbGpPWpGaD
Dextrothyroxine—THRA—Nuclear Receptors—PPARG—pancreatic cancer	0.00472	0.00972	CbGpPWpGaD
Dextrothyroxine—THRB—Nuclear Receptors—PPARG—pancreatic cancer	0.00472	0.00972	CbGpPWpGaD
Dextrothyroxine—TPO—Differentiation Pathway—NOTCH1—pancreatic cancer	0.00427	0.00878	CbGpPWpGaD
Dextrothyroxine—THRB—SIDS Susceptibility Pathways—FOXM1—pancreatic cancer	0.00413	0.00851	CbGpPWpGaD
Dextrothyroxine—TPO—Differentiation Pathway—EGF—pancreatic cancer	0.00413	0.00849	CbGpPWpGaD
Dextrothyroxine—THRA—Nuclear Receptor transcription pathway—PPARG—pancreatic cancer	0.00373	0.00768	CbGpPWpGaD
Dextrothyroxine—THRB—Nuclear Receptor transcription pathway—PPARG—pancreatic cancer	0.00373	0.00768	CbGpPWpGaD
Dextrothyroxine—SLCO4C1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00366	0.00753	CbGpPWpGaD
Dextrothyroxine—SLCO4A1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00366	0.00753	CbGpPWpGaD
Dextrothyroxine—THRB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—pancreatic cancer	0.00364	0.00749	CbGpPWpGaD
Dextrothyroxine—THRA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—pancreatic cancer	0.00364	0.00749	CbGpPWpGaD
Dextrothyroxine—THRA—Endochondral Ossification—PLAU—pancreatic cancer	0.00363	0.00746	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Cell surface interactions at the vascular wall—CD44—pancreatic cancer	0.0034	0.007	CbGpPWpGaD
Dextrothyroxine—THRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—pancreatic cancer	0.0034	0.00699	CbGpPWpGaD
Dextrothyroxine—THRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—pancreatic cancer	0.0034	0.00699	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00335	0.00689	CbGpPWpGaD
Dextrothyroxine—SLCO1C1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00307	0.00631	CbGpPWpGaD
Dextrothyroxine—THRB—SIDS Susceptibility Pathways—SST—pancreatic cancer	0.00299	0.00615	CbGpPWpGaD
Dextrothyroxine—SLCO4A1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.00298	0.00614	CbGpPWpGaD
Dextrothyroxine—SLCO4C1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.00298	0.00614	CbGpPWpGaD
Dextrothyroxine—Sweating increased—Irinotecan—pancreatic cancer	0.00283	0.0055	CcSEcCtD
Dextrothyroxine—Dysphagia—Fluorouracil—pancreatic cancer	0.00278	0.00541	CcSEcCtD
Dextrothyroxine—SLC7A5—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.00273	0.00561	CbGpPWpGaD
Dextrothyroxine—Angina pectoris—Fluorouracil—pancreatic cancer	0.00271	0.00527	CcSEcCtD
Dextrothyroxine—THRA—Generic Transcription Pathway—NR5A2—pancreatic cancer	0.00266	0.00547	CbGpPWpGaD
Dextrothyroxine—THRB—Generic Transcription Pathway—NR5A2—pancreatic cancer	0.00266	0.00547	CbGpPWpGaD
Dextrothyroxine—Weight decreased—Irinotecan—pancreatic cancer	0.00263	0.00511	CcSEcCtD
Dextrothyroxine—Angioedema—Tamoxifen—pancreatic cancer	0.00262	0.0051	CcSEcCtD
Dextrothyroxine—Flushing—Sunitinib—pancreatic cancer	0.00262	0.00509	CcSEcCtD
Dextrothyroxine—Cardiac failure congestive—Docetaxel—pancreatic cancer	0.00256	0.00498	CcSEcCtD
Dextrothyroxine—Acute coronary syndrome—Irinotecan—pancreatic cancer	0.00255	0.00497	CcSEcCtD
Dextrothyroxine—Myocardial infarction—Irinotecan—pancreatic cancer	0.00254	0.00494	CcSEcCtD
Dextrothyroxine—Arrhythmia—Sunitinib—pancreatic cancer	0.00252	0.0049	CcSEcCtD
Dextrothyroxine—SLCO1C1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.0025	0.00514	CbGpPWpGaD
Dextrothyroxine—TPO—Differentiation Pathway—VEGFA—pancreatic cancer	0.0025	0.00514	CbGpPWpGaD
Dextrothyroxine—Alopecia—Sunitinib—pancreatic cancer	0.00249	0.00485	CcSEcCtD
Dextrothyroxine—Acute coronary syndrome—Gemcitabine—pancreatic cancer	0.00249	0.00484	CcSEcCtD
Dextrothyroxine—Sweating—Irinotecan—pancreatic cancer	0.00248	0.00483	CcSEcCtD
Dextrothyroxine—Myocardial infarction—Gemcitabine—pancreatic cancer	0.00247	0.00481	CcSEcCtD
Dextrothyroxine—Acute coronary syndrome—Fluorouracil—pancreatic cancer	0.00244	0.00476	CcSEcCtD
Dextrothyroxine—Arthralgia—Tamoxifen—pancreatic cancer	0.00244	0.00475	CcSEcCtD
Dextrothyroxine—Anxiety—Tamoxifen—pancreatic cancer	0.00243	0.00473	CcSEcCtD
Dextrothyroxine—Myocardial infarction—Fluorouracil—pancreatic cancer	0.00243	0.00473	CcSEcCtD
Dextrothyroxine—Sweating—Gemcitabine—pancreatic cancer	0.00242	0.0047	CcSEcCtD
Dextrothyroxine—Arthralgia—Erlotinib—pancreatic cancer	0.00242	0.0047	CcSEcCtD
Dextrothyroxine—Anxiety—Erlotinib—pancreatic cancer	0.00241	0.00468	CcSEcCtD
Dextrothyroxine—Cardiac failure—Docetaxel—pancreatic cancer	0.00238	0.00463	CcSEcCtD
Dextrothyroxine—TPO—Differentiation Pathway—TGFB1—pancreatic cancer	0.00229	0.00472	CbGpPWpGaD
Dextrothyroxine—Shock—Erlotinib—pancreatic cancer	0.00228	0.00443	CcSEcCtD
Dextrothyroxine—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.00226	0.0044	CcSEcCtD
Dextrothyroxine—Angioedema—Sunitinib—pancreatic cancer	0.00224	0.00437	CcSEcCtD
Dextrothyroxine—SLCO4A1—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.00222	0.00456	CbGpPWpGaD
Dextrothyroxine—SLCO4C1—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.00222	0.00456	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—SRC—pancreatic cancer	0.00219	0.00451	CbGpPWpGaD
Dextrothyroxine—Dehydration—Docetaxel—pancreatic cancer	0.00216	0.0042	CcSEcCtD
Dextrothyroxine—Flushing—Irinotecan—pancreatic cancer	0.00216	0.0042	CcSEcCtD
Dextrothyroxine—THRA—Endochondral Ossification—MMP9—pancreatic cancer	0.00215	0.00442	CbGpPWpGaD
Dextrothyroxine—THRB—SIDS Susceptibility Pathways—HES1—pancreatic cancer	0.00214	0.00441	CbGpPWpGaD
Dextrothyroxine—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.00213	0.00415	CcSEcCtD
Dextrothyroxine—Convulsion—Sunitinib—pancreatic cancer	0.00213	0.00414	CcSEcCtD
Dextrothyroxine—Insomnia—Tamoxifen—pancreatic cancer	0.00212	0.00412	CcSEcCtD
Dextrothyroxine—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.00211	0.0041	CcSEcCtD
Dextrothyroxine—Insomnia—Erlotinib—pancreatic cancer	0.00209	0.00407	CcSEcCtD
Dextrothyroxine—Arthralgia—Sunitinib—pancreatic cancer	0.00209	0.00407	CcSEcCtD
Dextrothyroxine—Dyspnoea—Tamoxifen—pancreatic cancer	0.00209	0.00406	CcSEcCtD
Dextrothyroxine—Arrhythmia—Irinotecan—pancreatic cancer	0.00208	0.00404	CcSEcCtD
Dextrothyroxine—Dyspnoea—Erlotinib—pancreatic cancer	0.00206	0.00402	CcSEcCtD
Dextrothyroxine—Alopecia—Irinotecan—pancreatic cancer	0.00205	0.004	CcSEcCtD
Dextrothyroxine—SLC7A5—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.00203	0.00417	CbGpPWpGaD
Dextrothyroxine—Arrhythmia—Gemcitabine—pancreatic cancer	0.00202	0.00393	CcSEcCtD
Dextrothyroxine—Fatigue—Tamoxifen—pancreatic cancer	0.00202	0.00393	CcSEcCtD
Dextrothyroxine—Dysphagia—Docetaxel—pancreatic cancer	0.00201	0.00391	CcSEcCtD
Dextrothyroxine—Alopecia—Gemcitabine—pancreatic cancer	0.002	0.00389	CcSEcCtD
Dextrothyroxine—Fatigue—Erlotinib—pancreatic cancer	0.002	0.00388	CcSEcCtD
Dextrothyroxine—Arrhythmia—Fluorouracil—pancreatic cancer	0.00199	0.00387	CcSEcCtD
Dextrothyroxine—Shock—Sunitinib—pancreatic cancer	0.00197	0.00384	CcSEcCtD
Dextrothyroxine—Coma—Epirubicin—pancreatic cancer	0.00197	0.00384	CcSEcCtD
Dextrothyroxine—Alopecia—Fluorouracil—pancreatic cancer	0.00197	0.00383	CcSEcCtD
Dextrothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—TGFB1—pancreatic cancer	0.00196	0.00404	CbGpPWpGaD
Dextrothyroxine—Angina pectoris—Docetaxel—pancreatic cancer	0.00196	0.0038	CcSEcCtD
Dextrothyroxine—THRA—Endochondral Ossification—VEGFA—pancreatic cancer	0.00193	0.00397	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—EGFR—pancreatic cancer	0.00192	0.00396	CbGpPWpGaD
Dextrothyroxine—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00191	0.00372	CcSEcCtD
Dextrothyroxine—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00189	0.00368	CcSEcCtD
Dextrothyroxine—SLCO1B1—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.00187	0.00385	CbGpPWpGaD
Dextrothyroxine—Urticaria—Tamoxifen—pancreatic cancer	0.00186	0.00362	CcSEcCtD
Dextrothyroxine—SLCO1C1—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.00186	0.00382	CbGpPWpGaD
Dextrothyroxine—Abdominal pain—Tamoxifen—pancreatic cancer	0.00185	0.0036	CcSEcCtD
Dextrothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—TNF—pancreatic cancer	0.00183	0.00377	CbGpPWpGaD
Dextrothyroxine—Body temperature increased—Erlotinib—pancreatic cancer	0.00183	0.00356	CcSEcCtD
Dextrothyroxine—Abdominal pain—Erlotinib—pancreatic cancer	0.00183	0.00356	CcSEcCtD
Dextrothyroxine—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.00183	0.00355	CcSEcCtD
Dextrothyroxine—Coma—Doxorubicin—pancreatic cancer	0.00182	0.00355	CcSEcCtD
Dextrothyroxine—Weight decreased—Docetaxel—pancreatic cancer	0.00182	0.00353	CcSEcCtD
Dextrothyroxine—Insomnia—Sunitinib—pancreatic cancer	0.00181	0.00353	CcSEcCtD
Dextrothyroxine—THRB—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	0.0018	0.00369	CbGpPWpGaD
Dextrothyroxine—Dyspnoea—Sunitinib—pancreatic cancer	0.00179	0.00348	CcSEcCtD
Dextrothyroxine—THRA—Endochondral Ossification—TGFB1—pancreatic cancer	0.00177	0.00364	CbGpPWpGaD
Dextrothyroxine—Acute coronary syndrome—Docetaxel—pancreatic cancer	0.00176	0.00343	CcSEcCtD
Dextrothyroxine—Myocardial infarction—Docetaxel—pancreatic cancer	0.00175	0.00341	CcSEcCtD
Dextrothyroxine—Fatigue—Sunitinib—pancreatic cancer	0.00173	0.00336	CcSEcCtD
Dextrothyroxine—Cardiac failure congestive—Epirubicin—pancreatic cancer	0.00173	0.00336	CcSEcCtD
Dextrothyroxine—Asthenia—Tamoxifen—pancreatic cancer	0.00168	0.00327	CcSEcCtD
Dextrothyroxine—Convulsion—Fluorouracil—pancreatic cancer	0.00168	0.00327	CcSEcCtD
Dextrothyroxine—Arthralgia—Gemcitabine—pancreatic cancer	0.00168	0.00326	CcSEcCtD
Dextrothyroxine—Increased appetite—Epirubicin—pancreatic cancer	0.00167	0.00324	CcSEcCtD
Dextrothyroxine—Confusional state—Irinotecan—pancreatic cancer	0.00166	0.00324	CcSEcCtD
Dextrothyroxine—Asthenia—Erlotinib—pancreatic cancer	0.00166	0.00323	CcSEcCtD
Dextrothyroxine—Pruritus—Tamoxifen—pancreatic cancer	0.00166	0.00322	CcSEcCtD
Dextrothyroxine—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00164	0.00319	CcSEcCtD
Dextrothyroxine—Pruritus—Erlotinib—pancreatic cancer	0.00164	0.00319	CcSEcCtD
Dextrothyroxine—SLC7A5—Hemostasis—IFNA5—pancreatic cancer	0.00163	0.00335	CbGpPWpGaD
Dextrothyroxine—Shock—Irinotecan—pancreatic cancer	0.00162	0.00316	CcSEcCtD
Dextrothyroxine—Cardiac failure—Epirubicin—pancreatic cancer	0.00161	0.00312	CcSEcCtD
Dextrothyroxine—Hypoglycaemia—Epirubicin—pancreatic cancer	0.00161	0.00312	CcSEcCtD
Dextrothyroxine—Diarrhoea—Tamoxifen—pancreatic cancer	0.0016	0.00312	CcSEcCtD
Dextrothyroxine—Cardiac failure congestive—Doxorubicin—pancreatic cancer	0.0016	0.00311	CcSEcCtD
Dextrothyroxine—Hyperhidrosis—Irinotecan—pancreatic cancer	0.0016	0.00311	CcSEcCtD
Dextrothyroxine—Confusional state—Fluorouracil—pancreatic cancer	0.00159	0.0031	CcSEcCtD
Dextrothyroxine—Abdominal pain—Sunitinib—pancreatic cancer	0.00158	0.00308	CcSEcCtD
Dextrothyroxine—Body temperature increased—Sunitinib—pancreatic cancer	0.00158	0.00308	CcSEcCtD
Dextrothyroxine—Diarrhoea—Erlotinib—pancreatic cancer	0.00158	0.00308	CcSEcCtD
Dextrothyroxine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.00155	0.00303	CcSEcCtD
Dextrothyroxine—Tachycardia—Fluorouracil—pancreatic cancer	0.00154	0.003	CcSEcCtD
Dextrothyroxine—Increased appetite—Doxorubicin—pancreatic cancer	0.00154	0.003	CcSEcCtD
Dextrothyroxine—Affect lability—Epirubicin—pancreatic cancer	0.00154	0.003	CcSEcCtD
Dextrothyroxine—SLC7A5—Hemostasis—PPP2R5B—pancreatic cancer	0.00154	0.00317	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—CHD3—pancreatic cancer	0.00153	0.00314	CbGpPWpGaD
Dextrothyroxine—THRA—Gene Expression—CHD3—pancreatic cancer	0.00153	0.00314	CbGpPWpGaD
Dextrothyroxine—THRB—Generic Transcription Pathway—MEN1—pancreatic cancer	0.00153	0.00314	CbGpPWpGaD
Dextrothyroxine—THRA—Generic Transcription Pathway—MEN1—pancreatic cancer	0.00153	0.00314	CbGpPWpGaD
Dextrothyroxine—Insomnia—Irinotecan—pancreatic cancer	0.00149	0.00291	CcSEcCtD
Dextrothyroxine—Flushing—Docetaxel—pancreatic cancer	0.00149	0.0029	CcSEcCtD
Dextrothyroxine—Cardiac arrest—Epirubicin—pancreatic cancer	0.00149	0.0029	CcSEcCtD
Dextrothyroxine—Vomiting—Tamoxifen—pancreatic cancer	0.00149	0.0029	CcSEcCtD
Dextrothyroxine—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.00149	0.00289	CcSEcCtD
Dextrothyroxine—Cardiac failure—Doxorubicin—pancreatic cancer	0.00149	0.00289	CcSEcCtD
Dextrothyroxine—Mood swings—Epirubicin—pancreatic cancer	0.00148	0.00289	CcSEcCtD
Dextrothyroxine—SLC7A5—Cell surface interactions at the vascular wall—PIK3CB—pancreatic cancer	0.00148	0.00305	CbGpPWpGaD
Dextrothyroxine—Rash—Tamoxifen—pancreatic cancer	0.00148	0.00287	CcSEcCtD
Dextrothyroxine—Dermatitis—Tamoxifen—pancreatic cancer	0.00147	0.00287	CcSEcCtD
Dextrothyroxine—Vomiting—Erlotinib—pancreatic cancer	0.00147	0.00286	CcSEcCtD
Dextrothyroxine—Dyspnoea—Irinotecan—pancreatic cancer	0.00147	0.00286	CcSEcCtD
Dextrothyroxine—Headache—Tamoxifen—pancreatic cancer	0.00147	0.00285	CcSEcCtD
Dextrothyroxine—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.00147	0.00285	CcSEcCtD
Dextrothyroxine—Rash—Erlotinib—pancreatic cancer	0.00146	0.00284	CcSEcCtD
Dextrothyroxine—Dermatitis—Erlotinib—pancreatic cancer	0.00146	0.00284	CcSEcCtD
Dextrothyroxine—Dehydration—Epirubicin—pancreatic cancer	0.00146	0.00283	CcSEcCtD
Dextrothyroxine—Insomnia—Gemcitabine—pancreatic cancer	0.00145	0.00283	CcSEcCtD
Dextrothyroxine—Headache—Erlotinib—pancreatic cancer	0.00145	0.00282	CcSEcCtD
Dextrothyroxine—THRA—Generic Transcription Pathway—NOTCH4—pancreatic cancer	0.00145	0.00298	CbGpPWpGaD
Dextrothyroxine—THRB—Generic Transcription Pathway—NOTCH4—pancreatic cancer	0.00145	0.00298	CbGpPWpGaD
Dextrothyroxine—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.00144	0.0028	CcSEcCtD
Dextrothyroxine—Asthenia—Sunitinib—pancreatic cancer	0.00144	0.0028	CcSEcCtD
Dextrothyroxine—Arrhythmia—Docetaxel—pancreatic cancer	0.00144	0.00279	CcSEcCtD
Dextrothyroxine—Dyspnoea—Gemcitabine—pancreatic cancer	0.00143	0.00279	CcSEcCtD
Dextrothyroxine—Insomnia—Fluorouracil—pancreatic cancer	0.00143	0.00278	CcSEcCtD
Dextrothyroxine—Affect lability—Doxorubicin—pancreatic cancer	0.00143	0.00278	CcSEcCtD
Dextrothyroxine—Fatigue—Irinotecan—pancreatic cancer	0.00142	0.00277	CcSEcCtD
Dextrothyroxine—Alopecia—Docetaxel—pancreatic cancer	0.00142	0.00276	CcSEcCtD
Dextrothyroxine—Pruritus—Sunitinib—pancreatic cancer	0.00142	0.00276	CcSEcCtD
Dextrothyroxine—Dyspnoea—Fluorouracil—pancreatic cancer	0.00141	0.00274	CcSEcCtD
Dextrothyroxine—Nausea—Tamoxifen—pancreatic cancer	0.00139	0.0027	CcSEcCtD
Dextrothyroxine—Fatigue—Gemcitabine—pancreatic cancer	0.00139	0.0027	CcSEcCtD
Dextrothyroxine—Muscular weakness—Epirubicin—pancreatic cancer	0.00138	0.00269	CcSEcCtD
Dextrothyroxine—Cardiac arrest—Doxorubicin—pancreatic cancer	0.00138	0.00268	CcSEcCtD
Dextrothyroxine—Nausea—Erlotinib—pancreatic cancer	0.00138	0.00268	CcSEcCtD
Dextrothyroxine—Mood swings—Doxorubicin—pancreatic cancer	0.00137	0.00267	CcSEcCtD
Dextrothyroxine—Diarrhoea—Sunitinib—pancreatic cancer	0.00137	0.00267	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Irinotecan—pancreatic cancer	0.00136	0.00265	CcSEcCtD
Dextrothyroxine—Dysphagia—Epirubicin—pancreatic cancer	0.00135	0.00263	CcSEcCtD
Dextrothyroxine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00135	0.00263	CcSEcCtD
Dextrothyroxine—Dehydration—Doxorubicin—pancreatic cancer	0.00135	0.00262	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00133	0.00258	CcSEcCtD
Dextrothyroxine—Angina pectoris—Epirubicin—pancreatic cancer	0.00132	0.00257	CcSEcCtD
Dextrothyroxine—Body temperature increased—Irinotecan—pancreatic cancer	0.00131	0.00254	CcSEcCtD
Dextrothyroxine—Abdominal pain—Irinotecan—pancreatic cancer	0.00131	0.00254	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.0013	0.00254	CcSEcCtD
Dextrothyroxine—THRA—Gene Expression—NR5A2—pancreatic cancer	0.00128	0.00263	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—NR5A2—pancreatic cancer	0.00128	0.00263	CbGpPWpGaD
Dextrothyroxine—Muscular weakness—Doxorubicin—pancreatic cancer	0.00128	0.00249	CcSEcCtD
Dextrothyroxine—Vomiting—Sunitinib—pancreatic cancer	0.00127	0.00248	CcSEcCtD
Dextrothyroxine—Body temperature increased—Gemcitabine—pancreatic cancer	0.00127	0.00247	CcSEcCtD
Dextrothyroxine—Rash—Sunitinib—pancreatic cancer	0.00126	0.00246	CcSEcCtD
Dextrothyroxine—Dermatitis—Sunitinib—pancreatic cancer	0.00126	0.00246	CcSEcCtD
Dextrothyroxine—Urticaria—Fluorouracil—pancreatic cancer	0.00126	0.00244	CcSEcCtD
Dextrothyroxine—Headache—Sunitinib—pancreatic cancer	0.00126	0.00244	CcSEcCtD
Dextrothyroxine—Dysphagia—Doxorubicin—pancreatic cancer	0.00125	0.00244	CcSEcCtD
Dextrothyroxine—Body temperature increased—Fluorouracil—pancreatic cancer	0.00125	0.00243	CcSEcCtD
Dextrothyroxine—Palpitations—Docetaxel—pancreatic cancer	0.00124	0.0024	CcSEcCtD
Dextrothyroxine—THRA—Endochondral Ossification—AKT1—pancreatic cancer	0.00123	0.00253	CbGpPWpGaD
Dextrothyroxine—THRB—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.00123	0.00253	CbGpPWpGaD
Dextrothyroxine—THRA—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.00123	0.00253	CbGpPWpGaD
Dextrothyroxine—Weight decreased—Epirubicin—pancreatic cancer	0.00122	0.00238	CcSEcCtD
Dextrothyroxine—Angina pectoris—Doxorubicin—pancreatic cancer	0.00122	0.00237	CcSEcCtD
Dextrothyroxine—Convulsion—Docetaxel—pancreatic cancer	0.00121	0.00236	CcSEcCtD
Dextrothyroxine—Arthralgia—Docetaxel—pancreatic cancer	0.00119	0.00232	CcSEcCtD
Dextrothyroxine—Nausea—Sunitinib—pancreatic cancer	0.00119	0.00232	CcSEcCtD
Dextrothyroxine—SLC7A5—Cell surface interactions at the vascular wall—SRC—pancreatic cancer	0.00119	0.00244	CbGpPWpGaD
Dextrothyroxine—Asthenia—Irinotecan—pancreatic cancer	0.00118	0.0023	CcSEcCtD
Dextrothyroxine—SLCO1B1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00117	0.0024	CbGpPWpGaD
Dextrothyroxine—THRB—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	0.00116	0.0024	CbGpPWpGaD
Dextrothyroxine—Sweating—Epirubicin—pancreatic cancer	0.00116	0.00225	CcSEcCtD
Dextrothyroxine—Asthenia—Gemcitabine—pancreatic cancer	0.00115	0.00225	CcSEcCtD
Dextrothyroxine—Confusional state—Docetaxel—pancreatic cancer	0.00115	0.00224	CcSEcCtD
Dextrothyroxine—SLC7A5—Cell surface interactions at the vascular wall—NRAS—pancreatic cancer	0.00114	0.00235	CbGpPWpGaD
Dextrothyroxine—Pruritus—Gemcitabine—pancreatic cancer	0.00114	0.00221	CcSEcCtD
Dextrothyroxine—Weight decreased—Doxorubicin—pancreatic cancer	0.00113	0.0022	CcSEcCtD
Dextrothyroxine—Diarrhoea—Irinotecan—pancreatic cancer	0.00113	0.0022	CcSEcCtD
Dextrothyroxine—SLCO4A1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.00113	0.00232	CbGpPWpGaD
Dextrothyroxine—SLCO4C1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.00113	0.00232	CbGpPWpGaD
Dextrothyroxine—Shock—Docetaxel—pancreatic cancer	0.00112	0.00218	CcSEcCtD
Dextrothyroxine—Pruritus—Fluorouracil—pancreatic cancer	0.00112	0.00218	CcSEcCtD
Dextrothyroxine—THRB—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	0.00111	0.00229	CbGpPWpGaD
Dextrothyroxine—Tachycardia—Docetaxel—pancreatic cancer	0.00111	0.00217	CcSEcCtD
Dextrothyroxine—Diarrhoea—Gemcitabine—pancreatic cancer	0.0011	0.00214	CcSEcCtD
Dextrothyroxine—Diarrhoea—Fluorouracil—pancreatic cancer	0.00108	0.00211	CcSEcCtD
Dextrothyroxine—THRB—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	0.00107	0.00221	CbGpPWpGaD
Dextrothyroxine—Sweating—Doxorubicin—pancreatic cancer	0.00107	0.00208	CcSEcCtD
Dextrothyroxine—Vomiting—Irinotecan—pancreatic cancer	0.00105	0.00204	CcSEcCtD
Dextrothyroxine—Rash—Irinotecan—pancreatic cancer	0.00104	0.00203	CcSEcCtD
Dextrothyroxine—Dermatitis—Irinotecan—pancreatic cancer	0.00104	0.00202	CcSEcCtD
Dextrothyroxine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00104	0.00202	CcSEcCtD
Dextrothyroxine—Headache—Irinotecan—pancreatic cancer	0.00103	0.00201	CcSEcCtD
Dextrothyroxine—Insomnia—Docetaxel—pancreatic cancer	0.00103	0.00201	CcSEcCtD
Dextrothyroxine—SLC7A5—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.00103	0.00212	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—PRSS1—pancreatic cancer	0.00102	0.00211	CbGpPWpGaD
Dextrothyroxine—Vomiting—Gemcitabine—pancreatic cancer	0.00102	0.00199	CcSEcCtD
Dextrothyroxine—Dyspnoea—Docetaxel—pancreatic cancer	0.00102	0.00198	CcSEcCtD
Dextrothyroxine—Rash—Gemcitabine—pancreatic cancer	0.00101	0.00197	CcSEcCtD
Dextrothyroxine—Dermatitis—Gemcitabine—pancreatic cancer	0.00101	0.00197	CcSEcCtD
Dextrothyroxine—Headache—Gemcitabine—pancreatic cancer	0.00101	0.00196	CcSEcCtD
Dextrothyroxine—Flushing—Epirubicin—pancreatic cancer	0.00101	0.00196	CcSEcCtD
Dextrothyroxine—Vomiting—Fluorouracil—pancreatic cancer	0.00101	0.00196	CcSEcCtD
Dextrothyroxine—Rash—Fluorouracil—pancreatic cancer	0.000997	0.00194	CcSEcCtD
Dextrothyroxine—Dermatitis—Fluorouracil—pancreatic cancer	0.000996	0.00194	CcSEcCtD
Dextrothyroxine—Headache—Fluorouracil—pancreatic cancer	0.000991	0.00193	CcSEcCtD
Dextrothyroxine—Fatigue—Docetaxel—pancreatic cancer	0.000984	0.00191	CcSEcCtD
Dextrothyroxine—SLC7A5—Cell surface interactions at the vascular wall—KRAS—pancreatic cancer	0.000984	0.00202	CbGpPWpGaD
Dextrothyroxine—Nausea—Irinotecan—pancreatic cancer	0.000981	0.00191	CcSEcCtD
Dextrothyroxine—Arrhythmia—Epirubicin—pancreatic cancer	0.000968	0.00188	CcSEcCtD
Dextrothyroxine—Alopecia—Epirubicin—pancreatic cancer	0.000958	0.00186	CcSEcCtD
Dextrothyroxine—Nausea—Gemcitabine—pancreatic cancer	0.000955	0.00186	CcSEcCtD
Dextrothyroxine—SLCO1B1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000951	0.00196	CbGpPWpGaD
Dextrothyroxine—THRB—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	0.000946	0.00195	CbGpPWpGaD
Dextrothyroxine—SLCO1C1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000944	0.00194	CbGpPWpGaD
Dextrothyroxine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000941	0.00183	CcSEcCtD
Dextrothyroxine—Nausea—Fluorouracil—pancreatic cancer	0.000939	0.00183	CcSEcCtD
Dextrothyroxine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000933	0.00182	CcSEcCtD
Dextrothyroxine—Flushing—Doxorubicin—pancreatic cancer	0.000931	0.00181	CcSEcCtD
Dextrothyroxine—THRB—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000927	0.00191	CbGpPWpGaD
Dextrothyroxine—THRA—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000927	0.00191	CbGpPWpGaD
Dextrothyroxine—Tension—Epirubicin—pancreatic cancer	0.000926	0.0018	CcSEcCtD
Dextrothyroxine—SLC7A5—Hemostasis—CD44—pancreatic cancer	0.000922	0.0019	CbGpPWpGaD
Dextrothyroxine—Nervousness—Epirubicin—pancreatic cancer	0.000916	0.00178	CcSEcCtD
Dextrothyroxine—SLC7A5—Cell surface interactions at the vascular wall—PIK3CA—pancreatic cancer	0.000904	0.00186	CbGpPWpGaD
Dextrothyroxine—Abdominal pain—Docetaxel—pancreatic cancer	0.000902	0.00176	CcSEcCtD
Dextrothyroxine—Body temperature increased—Docetaxel—pancreatic cancer	0.000902	0.00176	CcSEcCtD
Dextrothyroxine—Arrhythmia—Doxorubicin—pancreatic cancer	0.000896	0.00174	CcSEcCtD
Dextrothyroxine—SLC7A5—Hemostasis—IFNA1—pancreatic cancer	0.000893	0.00184	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—ARG2—pancreatic cancer	0.000887	0.00183	CbGpPWpGaD
Dextrothyroxine—Alopecia—Doxorubicin—pancreatic cancer	0.000886	0.00172	CcSEcCtD
Dextrothyroxine—Agitation—Epirubicin—pancreatic cancer	0.000867	0.00169	CcSEcCtD
Dextrothyroxine—Tension—Doxorubicin—pancreatic cancer	0.000857	0.00167	CcSEcCtD
Dextrothyroxine—Nervousness—Doxorubicin—pancreatic cancer	0.000848	0.00165	CcSEcCtD
Dextrothyroxine—SLC7A5—Cell surface interactions at the vascular wall—HRAS—pancreatic cancer	0.000836	0.00172	CbGpPWpGaD
Dextrothyroxine—Palpitations—Epirubicin—pancreatic cancer	0.000834	0.00162	CcSEcCtD
Dextrothyroxine—SLC7A5—Hemostasis—IFNA2—pancreatic cancer	0.000831	0.00171	CbGpPWpGaD
Dextrothyroxine—Asthenia—Docetaxel—pancreatic cancer	0.000819	0.00159	CcSEcCtD
Dextrothyroxine—Convulsion—Epirubicin—pancreatic cancer	0.000817	0.00159	CcSEcCtD
Dextrothyroxine—THRB—SIDS Susceptibility Pathways—TNF—pancreatic cancer	0.000811	0.00167	CbGpPWpGaD
Dextrothyroxine—Pruritus—Docetaxel—pancreatic cancer	0.000808	0.00157	CcSEcCtD
Dextrothyroxine—Arthralgia—Epirubicin—pancreatic cancer	0.000803	0.00156	CcSEcCtD
Dextrothyroxine—Agitation—Doxorubicin—pancreatic cancer	0.000802	0.00156	CcSEcCtD
Dextrothyroxine—Anxiety—Epirubicin—pancreatic cancer	0.0008	0.00156	CcSEcCtD
Dextrothyroxine—Diarrhoea—Docetaxel—pancreatic cancer	0.000781	0.00152	CcSEcCtD
Dextrothyroxine—Confusional state—Epirubicin—pancreatic cancer	0.000776	0.00151	CcSEcCtD
Dextrothyroxine—TPO—Metabolism—TYMP—pancreatic cancer	0.000775	0.0016	CbGpPWpGaD
Dextrothyroxine—Palpitations—Doxorubicin—pancreatic cancer	0.000771	0.0015	CcSEcCtD
Dextrothyroxine—Shock—Epirubicin—pancreatic cancer	0.000757	0.00147	CcSEcCtD
Dextrothyroxine—Convulsion—Doxorubicin—pancreatic cancer	0.000756	0.00147	CcSEcCtD
Dextrothyroxine—Tachycardia—Epirubicin—pancreatic cancer	0.000751	0.00146	CcSEcCtD
Dextrothyroxine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000744	0.00145	CcSEcCtD
Dextrothyroxine—Arthralgia—Doxorubicin—pancreatic cancer	0.000743	0.00145	CcSEcCtD
Dextrothyroxine—Anxiety—Doxorubicin—pancreatic cancer	0.000741	0.00144	CcSEcCtD
Dextrothyroxine—THRA—Gene Expression—MEN1—pancreatic cancer	0.000735	0.00151	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—MEN1—pancreatic cancer	0.000735	0.00151	CbGpPWpGaD
Dextrothyroxine—Vomiting—Docetaxel—pancreatic cancer	0.000726	0.00141	CcSEcCtD
Dextrothyroxine—Rash—Docetaxel—pancreatic cancer	0.00072	0.0014	CcSEcCtD
Dextrothyroxine—Dermatitis—Docetaxel—pancreatic cancer	0.000719	0.0014	CcSEcCtD
Dextrothyroxine—Confusional state—Doxorubicin—pancreatic cancer	0.000718	0.0014	CcSEcCtD
Dextrothyroxine—Headache—Docetaxel—pancreatic cancer	0.000715	0.00139	CcSEcCtD
Dextrothyroxine—SLCO1B1—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000707	0.00145	CbGpPWpGaD
Dextrothyroxine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000701	0.00136	CcSEcCtD
Dextrothyroxine—Shock—Doxorubicin—pancreatic cancer	0.000701	0.00136	CcSEcCtD
Dextrothyroxine—THRA—Gene Expression—NOTCH4—pancreatic cancer	0.000697	0.00143	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—NOTCH4—pancreatic cancer	0.000697	0.00143	CbGpPWpGaD
Dextrothyroxine—Insomnia—Epirubicin—pancreatic cancer	0.000696	0.00135	CcSEcCtD
Dextrothyroxine—Tachycardia—Doxorubicin—pancreatic cancer	0.000695	0.00135	CcSEcCtD
Dextrothyroxine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000689	0.00134	CcSEcCtD
Dextrothyroxine—Dyspnoea—Epirubicin—pancreatic cancer	0.000686	0.00134	CcSEcCtD
Dextrothyroxine—THRB—Generic Transcription Pathway—NOTCH1—pancreatic cancer	0.000683	0.00141	CbGpPWpGaD
Dextrothyroxine—THRA—Generic Transcription Pathway—NOTCH1—pancreatic cancer	0.000683	0.00141	CbGpPWpGaD
Dextrothyroxine—Nausea—Docetaxel—pancreatic cancer	0.000678	0.00132	CcSEcCtD
Dextrothyroxine—THRB—Gene Expression—HSPA1B—pancreatic cancer	0.000665	0.00137	CbGpPWpGaD
Dextrothyroxine—THRA—Gene Expression—HSPA1B—pancreatic cancer	0.000665	0.00137	CbGpPWpGaD
Dextrothyroxine—Fatigue—Epirubicin—pancreatic cancer	0.000664	0.00129	CcSEcCtD
Dextrothyroxine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000649	0.00126	CcSEcCtD
Dextrothyroxine—THRB—Generic Transcription Pathway—PPARG—pancreatic cancer	0.000645	0.00133	CbGpPWpGaD
Dextrothyroxine—THRA—Generic Transcription Pathway—PPARG—pancreatic cancer	0.000645	0.00133	CbGpPWpGaD
Dextrothyroxine—Insomnia—Doxorubicin—pancreatic cancer	0.000644	0.00125	CcSEcCtD
Dextrothyroxine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000635	0.00124	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Epirubicin—pancreatic cancer	0.000634	0.00123	CcSEcCtD
Dextrothyroxine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.00063	0.00122	CcSEcCtD
Dextrothyroxine—TPO—Metabolism—GLP1R—pancreatic cancer	0.000625	0.00129	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—DPYD—pancreatic cancer	0.000615	0.00127	CbGpPWpGaD
Dextrothyroxine—Fatigue—Doxorubicin—pancreatic cancer	0.000614	0.00119	CcSEcCtD
Dextrothyroxine—Urticaria—Epirubicin—pancreatic cancer	0.000612	0.00119	CcSEcCtD
Dextrothyroxine—Abdominal pain—Epirubicin—pancreatic cancer	0.000609	0.00118	CcSEcCtD
Dextrothyroxine—Body temperature increased—Epirubicin—pancreatic cancer	0.000609	0.00118	CcSEcCtD
Dextrothyroxine—THRB—Gene Expression—EZH2—pancreatic cancer	0.000605	0.00125	CbGpPWpGaD
Dextrothyroxine—THRA—Gene Expression—EZH2—pancreatic cancer	0.000605	0.00125	CbGpPWpGaD
Dextrothyroxine—THRA—Gene Expression—NOTCH3—pancreatic cancer	0.000593	0.00122	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—NOTCH3—pancreatic cancer	0.000593	0.00122	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—PLAU—pancreatic cancer	0.00059	0.00121	CbGpPWpGaD
Dextrothyroxine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000587	0.00114	CcSEcCtD
Dextrothyroxine—TPO—Metabolism—SLC2A2—pancreatic cancer	0.000583	0.0012	CbGpPWpGaD
Dextrothyroxine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000583	0.00113	CcSEcCtD
Dextrothyroxine—Urticaria—Doxorubicin—pancreatic cancer	0.000566	0.0011	CcSEcCtD
Dextrothyroxine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000563	0.0011	CcSEcCtD
Dextrothyroxine—Abdominal pain—Doxorubicin—pancreatic cancer	0.000563	0.0011	CcSEcCtD
Dextrothyroxine—THRA—Gene Expression—HSPA1A—pancreatic cancer	0.000561	0.00115	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—HSPA1A—pancreatic cancer	0.000561	0.00115	CbGpPWpGaD
Dextrothyroxine—Asthenia—Epirubicin—pancreatic cancer	0.000552	0.00107	CcSEcCtD
Dextrothyroxine—Pruritus—Epirubicin—pancreatic cancer	0.000545	0.00106	CcSEcCtD
Dextrothyroxine—Diarrhoea—Epirubicin—pancreatic cancer	0.000527	0.00102	CcSEcCtD
Dextrothyroxine—SLC7A5—Hemostasis—PIK3CG—pancreatic cancer	0.000525	0.00108	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—EGF—pancreatic cancer	0.000519	0.00107	CbGpPWpGaD
Dextrothyroxine—Asthenia—Doxorubicin—pancreatic cancer	0.000511	0.000994	CcSEcCtD
Dextrothyroxine—Pruritus—Doxorubicin—pancreatic cancer	0.000504	0.000981	CcSEcCtD
Dextrothyroxine—Vomiting—Epirubicin—pancreatic cancer	0.00049	0.000952	CcSEcCtD
Dextrothyroxine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000487	0.000948	CcSEcCtD
Dextrothyroxine—Rash—Epirubicin—pancreatic cancer	0.000485	0.000944	CcSEcCtD
Dextrothyroxine—Dermatitis—Epirubicin—pancreatic cancer	0.000485	0.000944	CcSEcCtD
Dextrothyroxine—Headache—Epirubicin—pancreatic cancer	0.000482	0.000938	CcSEcCtD
Dextrothyroxine—SLC7A5—Hemostasis—PIK3CD—pancreatic cancer	0.000461	0.000949	CbGpPWpGaD
Dextrothyroxine—Nausea—Epirubicin—pancreatic cancer	0.000457	0.00089	CcSEcCtD
Dextrothyroxine—Vomiting—Doxorubicin—pancreatic cancer	0.000453	0.000881	CcSEcCtD
Dextrothyroxine—TPO—Metabolism—CD44—pancreatic cancer	0.000452	0.00093	CbGpPWpGaD
Dextrothyroxine—Rash—Doxorubicin—pancreatic cancer	0.000449	0.000874	CcSEcCtD
Dextrothyroxine—Dermatitis—Doxorubicin—pancreatic cancer	0.000449	0.000873	CcSEcCtD
Dextrothyroxine—THRA—Gene Expression—SMAD4—pancreatic cancer	0.000446	0.000918	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—SMAD4—pancreatic cancer	0.000446	0.000918	CbGpPWpGaD
Dextrothyroxine—Headache—Doxorubicin—pancreatic cancer	0.000446	0.000868	CcSEcCtD
Dextrothyroxine—TPO—Metabolism—GCG—pancreatic cancer	0.000433	0.000891	CbGpPWpGaD
Dextrothyroxine—Nausea—Doxorubicin—pancreatic cancer	0.000423	0.000823	CcSEcCtD
Dextrothyroxine—TPO—Metabolism—STK11—pancreatic cancer	0.000407	0.000838	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—PIK3CB—pancreatic cancer	0.000402	0.000827	CbGpPWpGaD
Dextrothyroxine—THRA—Generic Transcription Pathway—MYC—pancreatic cancer	0.000368	0.000757	CbGpPWpGaD
Dextrothyroxine—THRB—Generic Transcription Pathway—MYC—pancreatic cancer	0.000368	0.000757	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000359	0.000739	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—TYMS—pancreatic cancer	0.00035	0.000721	CbGpPWpGaD
Dextrothyroxine—THRA—Gene Expression—NOTCH1—pancreatic cancer	0.000329	0.000677	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—NOTCH1—pancreatic cancer	0.000329	0.000677	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—SRC—pancreatic cancer	0.000322	0.000663	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—VEGFA—pancreatic cancer	0.000314	0.000646	CbGpPWpGaD
Dextrothyroxine—THRA—Gene Expression—PPARG—pancreatic cancer	0.000311	0.000639	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—PPARG—pancreatic cancer	0.000311	0.000639	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—NRAS—pancreatic cancer	0.00031	0.000638	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—PRSS1—pancreatic cancer	0.000295	0.000607	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—TGFB1—pancreatic cancer	0.000288	0.000593	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—APOE—pancreatic cancer	0.000285	0.000586	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—KRAS—pancreatic cancer	0.000267	0.000549	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—PIK3CG—pancreatic cancer	0.000257	0.000529	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—ARG2—pancreatic cancer	0.000256	0.000526	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—PPARG—pancreatic cancer	0.000248	0.000511	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—PIK3CA—pancreatic cancer	0.000245	0.000504	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—TP53—pancreatic cancer	0.000237	0.000488	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—HRAS—pancreatic cancer	0.000227	0.000467	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—PIK3CD—pancreatic cancer	0.000226	0.000465	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—TYMP—pancreatic cancer	0.000224	0.00046	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—AKT1—pancreatic cancer	0.0002	0.000412	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—PIK3CB—pancreatic cancer	0.000197	0.000405	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—PTGS2—pancreatic cancer	0.000195	0.000402	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	0.000185	0.00038	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—GLP1R—pancreatic cancer	0.00018	0.000371	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—DPYD—pancreatic cancer	0.000177	0.000365	CbGpPWpGaD
Dextrothyroxine—THRA—Gene Expression—MYC—pancreatic cancer	0.000177	0.000364	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—MYC—pancreatic cancer	0.000177	0.000364	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—PTEN—pancreatic cancer	0.00017	0.00035	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—SLC2A2—pancreatic cancer	0.000168	0.000346	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	0.000167	0.000343	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	0.000161	0.000331	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	0.000146	0.000301	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—CD44—pancreatic cancer	0.00013	0.000268	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	0.000128	0.000263	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	0.000126	0.00026	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—GCG—pancreatic cancer	0.000125	0.000257	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—AKT1—pancreatic cancer	0.000123	0.000253	CbGpPWpGaD
Dextrothyroxine—THRA—Gene Expression—AKT1—pancreatic cancer	0.000123	0.000253	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—PIK3CA—pancreatic cancer	0.00012	0.000247	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—STK11—pancreatic cancer	0.000117	0.000242	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	0.00011	0.000227	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—TYMS—pancreatic cancer	0.000101	0.000208	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—AKT1—pancreatic cancer	9.81e-05	0.000202	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—APOE—pancreatic cancer	8.22e-05	0.000169	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	7.78e-05	0.00016	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—PIK3CG—pancreatic cancer	7.42e-05	0.000153	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—PPARG—pancreatic cancer	7.16e-05	0.000147	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—PIK3CD—pancreatic cancer	6.52e-05	0.000134	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—PIK3CB—pancreatic cancer	5.68e-05	0.000117	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—PTGS2—pancreatic cancer	5.63e-05	0.000116	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—PTEN—pancreatic cancer	4.91e-05	0.000101	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—PIK3CA—pancreatic cancer	3.46e-05	7.13e-05	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—AKT1—pancreatic cancer	2.83e-05	5.82e-05	CbGpPWpGaD
